期刊文献+

铜绿假单胞菌的耐药性及多重耐药机制 被引量:1

Analysis of the resistance and the mechanism of multidrug resistante in Pseudomonas aeruginosa
下载PDF
导出
摘要 目的了解铜绿假单胞菌临床分离株的耐药性及耐药机制,指导临床合理选用抗生素。方法应用英国先德微生物分析系统检测药物敏感性,通过改良酶提取物头孢西丁和头孢曲松三维试验检测AmpC酶和ESBLs,K-B纸片扩散法检测金属β内酰胺酶。结果74株临床分离铜绿假单胞菌对亚胺培南的敏感率最高,敏感率达82.4%。对头孢吡肟、阿米卡星、派拉西林、环丙沙星、妥布霉素的敏感性较高。单产ESBLs、同时产ESBLs和AmpC酶、单产AmpC酶和单产金属β内酰胺酶的检出率分别为16.2%,9.4%,5.4%,4.0%。结论临床分离铜绿假单胞菌的耐约现象不容忽视,产生高活性β内酰胺酶是导致其耐药的机制之一,亚胺培南仍是治疗铜绿假单胞菌感染最有效的约物。 Objective To i1nvestigate the antimicrobial.resistance and the mechanismof multidrug resistance in PseudomonasP.aeruginosa) clinical isolates,for guiding the rational use of antibiotics.Methods Antimicrobial susceptibility tests were done by the Sensititre-lactamases and/or extended-Spectrum β-lactamasesESBLs) by modified three-dimensional extract test,while metallo β-lactamasesMBLs) were identified using Kirby-Bauer disk diffusions method.Result The susceptbiliy rate of 74 P.aeruginosa clinical isolates to imipenem was the highest about82.4%,and to cefepime,amikacin、piperacillin Ciprofloxacin tobramicin were higher.ESBLs combined with AmpC β-lactamases,AmpC β-lactamases and MBLs producing strains were detected in 16.2%、9.4%、5.4% and 4.0% of P,aeruginosa respectively.Conclusion The resistant phenomenon of P.aeruginosa clinical isolates shoud not be ignored,production of high active β-lactamases is one of resistant mechanisms in P.aeruginosa,imipenem is still the best choice for treating infection caused by P.aeruginosa.
作者 郭涛 汤华
出处 《医学检验与临床》 2006年第1期46-47,共2页 Medical Laboratory Science and Clinics
  • 相关文献

参考文献6

二级参考文献47

  • 1许宏涛,陈东科,俞云松,张秀珍.多重耐药铜绿假单胞菌产β-内酰胺酶耐药机制研究[J].中华医院感染学杂志,2005,15(1):20-22. 被引量:81
  • 2许宏涛,张秀珍.医院感染铜绿假单胞菌多重耐药机制的研究[J].中国抗感染化疗杂志,2005,5(3):141-145. 被引量:58
  • 3[1]Takenouchi T,Sakagawa E,Sugawara M.Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones[J]. Antimicrob Agents Chemother, 1999, 43(2): 406-409.
  • 4[2]Mouneimne H, Jarlier V, Cambau E, et al. Type Ⅱ topoisomerase mutations in ciprofloxacin-resistance strains of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1999, 43(1): 62-66.
  • 5[3]Li XZ, Livermore DM, Nikaiclo H. Role of efflux pumps in intrinsic resistance of Pseudomonas aeruginosa resistance to tetracycline, chloramphenicol and norfloxacin[J]. Antimicrob Agents Chemother, 1994, 38: 1732-1741.
  • 6[4]Poole K, Bianco N, Neshat S, et al. Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1997, 41: 853-856.
  • 7[5]Masuda N, Gotoh N, Ohya S, et al. Quantitative correlation between susceptibility and oprJ production in nfxB mutations of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1996, 40: 903-909.
  • 8[1]Stove CK, Pham QX, et al. Complete genome sequence of Pseudomonas Aeruginosa PAO1 an opportunistic pathogen. Nature, 2000; 406: 959~ 964
  • 9[2]National Committee for Clinical Laboratory Standards . Performance standards for antimicrobiol susceptibility testing . fourteenth informational supplement. M2-A8 and M7-A6 . National Committee for Clinical Laboratory Standards . 2004; 24( 1 ): 35~ 38
  • 10[4]Coudron PE. Moland ES. Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. Journal of clinical microbiology, 2000; 38( 5 ): 1791 ~ 1796

共引文献300

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部